BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 32530514)

  • 1. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
    Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
    Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1.
    Radtke A; Hennig F; Ikogho R; Hammel J; Anheuser P; Wülfing C; Belge G; Dieckmann KP
    Urol Int; 2018; 100(4):470-475. PubMed ID: 29698973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular germ cell tumour cells release microRNA-containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment.
    Alonso-Crisostomo L; Trendell J; Ferraresso M; Bailey S; Ward D; Scurlock ZGL; Wenlock SC; Bastos CAP; Jugdaohsingh R; Faria NJ; Enright AJ; Scarpini CG; Coleman N; Murray MJ
    Int J Cancer; 2024 Jan; 154(2):372-388. PubMed ID: 37632231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP
    Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.
    Anheuser P; Radtke A; Wülfing C; Kranz J; Belge G; Dieckmann KP
    Urol Int; 2017; 99(1):98-103. PubMed ID: 28586780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection.
    Konneh B; Lafin JT; Howard J; Gerald T; Amini A; Savelyeva A; Woldu SL; Lewis CM; Jia L; Margulis V; Coleman N; Scarpini C; Frazier AL; Murray MJ; Amatruda JF; Bagrodia A
    Andrology; 2023 May; 11(4):634-640. PubMed ID: 36254623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures.
    Santarosa Vieira AG; da Silva LS; Albino da Silva EC; Laus AC; Faria TMV; van Helvoort Lengert A; Martins GE; de Oliveira MA; Reis RM; Lopes LF; Pinto MT
    Mol Oncol; 2024 Jun; 18(6):1593-1607. PubMed ID: 38725152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
    J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.
    Almstrup K; Lobo J; Mørup N; Belge G; Rajpert-De Meyts E; Looijenga LHJ; Dieckmann KP
    Nat Rev Urol; 2020 Apr; 17(4):201-213. PubMed ID: 32157202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular signatures identified by integrating gene expression and methylation in non-seminoma and seminoma of testicular germ cell tumours.
    Mallik S; Qin G; Jia P; Zhao Z
    Epigenetics; 2021; 16(2):162-176. PubMed ID: 32615059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA and transcription factor co-regulatory networks and subtype classification of seminoma and non-seminoma in testicular germ cell tumors.
    Qin G; Mallik S; Mitra R; Li A; Jia P; Eischen CM; Zhao Z
    Sci Rep; 2020 Jan; 10(1):852. PubMed ID: 31965022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ cell tumour subtypes display differential expression of microRNA371a-3p.
    Vilela-Salgueiro B; Barros-Silva D; Lobo J; Costa AL; Guimarães R; Cantante M; Lopes P; Braga I; Oliveira J; Henrique R; Jerónimo C
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
    van Agthoven T; Eijkenboom WMH; Looijenga LHJ
    Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
    Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G
    Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
    Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ
    Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers.
    Cheng WT; Rosario R; Muthukaruppan A; Wilson MK; Payne K; Fong PC; Shelling AN; Blenkiron C
    Clin Epigenetics; 2017; 9():72. PubMed ID: 28736583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives.
    Ditonno F; Franco A; Manfredi C; Fasanella D; Abate M; La Rocca R; Crocerossa F; Iossa V; Falagario UG; Cirillo L; Altieri VM; Di Mauro E; Crocetto F; Barone B; Cilio S; Pandolfo SD; Aveta A; Mirone V; Franzese CA; Arcaniolo D; Napolitano L
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004082
    [No Abstract]   [Full Text] [Related]  

  • 20. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.